The Treaty of Versailles, which was signed in 1919 by Germany and the Allied powers to end World War I, brought an abrupt end to the successful company's expansion plans. Bayer's foreign assets were seized, along with its patent and trademark rights, which included both the Bayer Cross and Aspirin™, an extremely important product. At the time, the Alien Property Custodian sold the patents of the German chemical industry for only US$ 250,000 - a heavy blow for the Farbenfabriken. This meant that in the United States, the Bayer name no longer belonged to Bayer, but to Sterling Drug. It wasn't until 1994 that Bayer regained the right to use its name and corporate logo in the United States by acquiring the North American non-prescription drug business of Sterling Winthrop. After more than 74 years, however, the price had risen dramatically: Bayer paid $1 billion for the right to use a uniform corporate logo throughout the world.